Other languages AVITA Medical, Inc.

Equities

RCEL

US05380C1027

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-28 pm EDT			5-day change	1st Jan Change
8.63 ^USD	+6.54%		+6.02%	-37.10%

May. 22	Transcript : AVITA Medical, Inc. - Special Call
May. 14	Cantor Fitzgerald Trims Price Target on Avita Medical to $21 From $22, Maintains Overweight Rating	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Avita Medical Widens Q1 Loss as Sales, Marketing Expense Jumps; Shares Up 10%	May. 13
AVITA Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13
Avita Medical Lowers Q1 Revenue Guidance on Slower New Account Approvals	Apr. 10
AVITA Medical, Inc. Revises Revenue Guidance for the First Quarter Ended March 31, 2024 and Full Year Fiscal 2024	Apr. 10
AVITA Medical Submits Additional RECELL GO PMA Supplement Information to US FDA	Feb. 29
AVITA Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 22
AVITA Medical, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 22
AVITA Medical, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024	Feb. 22
Sector Update: Health Care Stocks Softer Thursday Afternoon	Jan. 11
Sector Update: Health Care Stocks Mixed Premarket Thursday	Jan. 11
Sector Update: Health Care	Jan. 11
Avita Medical Signs US Distribution Agreement for Wound Healing Products	Jan. 11
Avita Medical Signs Deal with Stedical Scientific for US Distribution of PermeaDerm	Jan. 10
AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific	Jan. 10
Avita Medical, Inc. Provides Preliminary Revenue Guidance for Fourth Quarter and Full-Year 2023 and First Quarter and Year 2024	Jan. 10
Sector Update: Health Care Stocks Rise Tuesday Afternoon	Nov. 21
Sector Update: Health Care Stocks Mixed Premarket Tuesday	Nov. 21
Avita Medical Lowers Fiscal 2023 Revenue Guidance	Nov. 21
Avita Medical Lowers Guidance for 2023 Commercial Revenue	Nov. 20
AVITA Medical, Inc. Updates Revenue Guidance for the Year 2023	Nov. 20

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages AVITA Medical, Inc.

Equities

RCEL

US05380C1027

Other languages

Filters